Women with chronic kidney disease are less likely than men to be diagnosed, represented in research and given treatments that have been properly tested in them. That is the central finding of a new ...
MedPage Today on MSN
B-Cell Depleter Nabs Phase III Win in Autoimmune Kidney Disease
Obinutuzumab tops immunosuppressant tacrolimus for membranous nephropathy remissions ...
Three separate papers on the kidney drug finerenone landed in the New England Journal of Medicine, The Lancet, and JAMA on the same day, each reporting that the drug met its primary endpoints. The ...
Objectives Despite adherence to guideline-based pharmacotherapy, many people with diabetic kidney disease (DKD) were unable to meet glycaemic and blood pressure targets. The purpose of this paper was ...
Hypertension is a growing crisis in Bangladesh, with 23.5% of adults affected. Urgent action is needed for financing ...
Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...
HCM City has recorded sharp increases in cases of hand, foot and mouth disease (HFMD) and dengue fever, with several related deaths reported since the beginning of the year, according to the municipal ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Organised under the auspices of the International Osteoporosis Foundation (IOF) and the European Society for Clinical and ...
Thank you, Morgan, and thank you all for joining us for our fiscal year 2025 earnings call. With me this morning are Dr. Julie Krop, our Chief Medical Officer; and Scott Kellen, our Chief Financial ...
Polar bears aren't white, strawberries aren't berries and the Earth isn't round—we'll have you rethinking everything you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results